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Non-communicable diseases and related
risk behaviors among men and women
living with HIV in Cambodia: findings from
a cross-sectional study
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Hattie Pearson2, Gitau Mburu3,4, Carinne Brody2 and Siyan Yi1,2*
Abstract
Background: There is a growing concern for an increasing burden of non-communicable diseases (NCDs) in people
living with HIV. This concern is evident especially in developing countries where dietary and lifestyle risk factors
associated with NCDs are becoming more prominent. This study explored the prevalence of diabetes mellitus,
hypertension, and hyperlipidemia and related risk factors in men and women living with HIV in Cambodia.
Methods: This cross-sectional study was conducted among 510 adult people living with HIV randomly selected from
one city and four provinces in Cambodia. A structured questionnaire was used to collect data on socio-demographic
characteristics, health behaviors, medical history, and antiretroviral therapy (ART). Anthropometric and biological
measurements were performed. Descriptive statistics were used to calculate proportions and means of the measured
variables. An independent Student’s t-test was used for continuous variables. Chi square test or Fisher’s exact test was
used for categorical variables to explore gender differences.
Results: Prevalence of diabetes mellitus, hypertension, and hyperlipidemia was 9.4, 15.1, and 33.7%, respectively. The
prevalence of hyperlipidemia was significantly higher among men compared to women. Mean systolic and diastolic
blood pressures were also significantly higher among men. Regarding risk factors, 17.3% of participants were
overweight, and 4.1% were obese. Tobacco and alcohol use was common, particularly among men. Fruit and
vegetable consumption was considerably low among both men and women. Physical activity levels were also low.
About 40% of participants reported having a job that involved mostly sitting or standing; 46.3% reported engaging in
moderate activities; and 11.8% reported engaging in vigorous activities during leisure time. A significantly higher
proportion of men compared to women engaged in vigorous activities both at work and during leisure time.
Conclusions: The prevalence of diabetes mellitus, hypertension, and hyperlipidemia among men and women living
with HIV in Cambodia is considerably high. Related risk factors were also common. Given the comorbidity of NCDs and
HIV, policy and programmatic interventions are required, including integration of NCD screening into HIV programs.
Distinctions in the levels of diseases and in health behaviors between men and women suggest that interventions
need to be tailor-made and gender-specific, targeting their respective diseases and behaviors.
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Background
In developing countries, the epidemic of human immuno-
deficiency virus (HIV) and the growing prevalence of
non-communicable diseases (NCDs) are intercon-
nected health crises [1]. Cardiovascular disease, hyper-
tension, and diabetes mellitus all have direct and
indirect relationships with HIV and antiretroviral ther-
apy (ART). There is also a growing prevalence of
NCDs in the populations of many developing countries
due to dietary and lifestyle changes and the increase of
life expectancies [1].
In recent years, research has elucidated ways in which
HIV increases the risk for several NCDs. HIV can cause
inflammation in the blood vessels, promoting atheroscler-
osis and the formation of high-risk plaque, all of which in-
crease the risk for cardiovascular disease [2]. Additionally,
some antiretroviral drugs used to treat HIV have also been
shown to increase cholesterol levels, abdominal fat, and
blood pressure [3]. ART has also been linked to the de-
velopment of insulin resistance and metabolic syndrome
[3, 4]. In Botswana, Malawi, Nigeria, Tanzania, and
Zimbabwe, researchers found that people living with HIV
on ART regimens experienced hypertension and diabetes
mellitus at higher rates compared to the general popula-
tion [5–10].
With improved access to HIV prevention and treatment
programs, there has been progress in reducing HIV trans-
mission, morbidity, and mortality in developing countries.
In Cambodia, according to the National Center for HIV/
AIDS Dermatology and STD (NCHADS), the overall HIV
prevalence among individuals aged 15–49 years old has
declined from approximately 2% in 1998 to 0.6% in 2013
[11] and 0.3% in 2014 [12]. In addition, 78.9% of people
living with HIV were on ART by the end of 2015 [13]. Ac-
cording to the Cambodia Country Progress Report, the
total number of people living with HIV in Cambodia was
estimated at 75,000 in 2014 [14]. National figures on char-
acteristics of people living with HIV are not available.
Based on program data from KHANA, the largest
community-based implementer of HIV prevention and
care services in Cambodia, of 16,596 clients under its
country-wide coverage by December 2016, 59% were fe-
male, 93% were over 14 years old, and 31% lived in rural
areas. Moreover, 12% of the clients were identified as
‘poor’ and 69% as in ‘greatest need.’
Despite the decline in the HIV prevalence rate among
the general population, that among key populations
(KPs) was still high. For instance, the HIV prevalence
rate among female entertainment workers (FEW) having
more than seven sexual partners per week was 14% in
2010, and those having seven or less sexual partners per
week was 4.1% in the same year [14]. Men who have
sex with men (MSM), people who inject drugs (PWID),
and transgender women (TG women) had the HIV
prevalence rate of 2.3% in 2014, 24.8% in 2012, and 5.9%
in 2016, respectively [15–17].
Although Cambodia has been triumphant in curbing
the HIV epidemic, the link to and rise of NCDs may
complicate the health status of people living with HIV.
The Cambodian populace has high levels of NCDs. The
prevalence of diabetes mellitus and hypertension in the
general adult population is estimated to be between 5
and 10% and 11%, respectively [18–20]. A 2010 joint
Ministry of Health (MOH) and World Health Organization
(WHO)‘s STEP survey estimated the prevalence of raised
blood pressure, diabetes mellitus, and raised blood choles-
terol to be 11, 2.9, and 20%, respectively [20]. This survey
also found a high prevalence of risk factors among Cambo-
dians, including a high prevalence of raised blood choles-
terol (20%), low prevalence of adequate fruits and vegetable
consumption (80%), and a high prevalence of current alco-
hol use (50%) [20]. Given the interactions between HIV,
ART, and metabolic diseases, the prevalence of diabetes
mellitus and hypertension in people living with HIV may
be higher than that in the general population.
Understanding the scope and nature of NCDs among
people living with HIV is essential for public health
planning for the prevention and treatment of NCDs
among these people. There is an immediate need to
identify the best clinical interventions and health policy
strategies to manage these overlapping epidemics [21].
However, there has been no research quantifying the
prevalence of NCDs and risk factors in people living
with HIV in Cambodia. This study was therefore con-
ducted to document the prevalence of common NCDs
and associated risk factors among adult male and female
people living with HIV. Results of this study will inform
prevention, control, and management of NCDs in this
population.
Methods
Study design, sites, and population
This cross-sectional study was conducted among 510
adult male and female people living with HIV in the cap-
ital city of Phnom Penh and four provinces including
Battambang, Pursat, Siem Reap, and Takeo. The number
of people living with HIV in the selected sites repre-
sented more than 70% of this population in coverage
areas of KHANA. To be eligible for this study, an indi-
vidual was required to: (1) be 21 years old or older, (2)
be able to communicate in Khmer, (3) have been living
with HIV for at least 12 months, (4) be able to provide
verbal consent to participate in the study, and (5) be able
to present themselves at the selected health center on
the day of the data collection. Pregnant women and
breast-feeding mothers were excluded from the study
due to possible confounding metabolic changes during
pregnancy.
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Sampling procedures
Participants were recruited from ART clinics located in
both rural and urban communities from the aforemen-
tioned study sites in order to get a representative sample
of the study population across the country. Rural com-
munities referred to all locations within each province
except its provincial town, while urban communities re-
ferred to all locations in the capital city and the provin-
cial town of each province. To assess the impact of ART
regimens on NCDs, the research team recruited a par-
ticipant not on ART (pre-ART) for every participant on
ART (on ART for ≥12 months). Furthermore, efforts
were made to recruit as many men as possible for both
pre-ART and ART groups since a similar study in
Tanzania found that more women (70%) in comparison
to men participated in the study [7].
We used the estimated nation-wide figure of people
living with HIV in 2014 (75,000 persons) [14] as a basis
for calculating the sample size. The following formula
was used to compute the minimum sample size based
on these parameters: Z = the level of statistical signifi-
cance with a 95% confidence interval (CI) of 1.96, and a
precision level of 0.05.
The result of this calculation was 383 participants. To
account for non-respondents, 20% was added to the
minimum sample size, which totaled to 460 participants.
Since the majority (>85%) of people living with HIV in
the country were currently receiving ART, all of those
who were eligible and in the pre-ART category were in-
cluded if they were willing to participate in the study.
The probability-proportionate-to-size sampling method
was used to select the number of ART clinics from each
study site. Based on an estimated average number of
people living with HIV at each ART clinic, 25 clinics were
needed to recruit 460 participants. A two-stage cluster
sampling method was used to select the study sample
from 25 ART clinics. The first stage was to randomly se-
lect an eligible ART clinic in each study site. After dividing
the required number of 460 people living with HIV by 25
ART clinics, the even distribution of participants among
all sites was at least 19 participants. Thus, ART clinics
were randomly selected from the list of the clinics that
had a minimum number of 20 people living with HIV.
The second stage involved the selection of participants to
participate in the study. Considering an assumption that
only 50–60% of people living with HIV at each ART clinic
would be able to participate in the study due to possible
unexpected migration, 15 eligible people living with HIV
from each ART clinic were randomly invited to join the
study by the field coordinator. The selection of partici-
pants in each site was made using simple random
method by picking every odd-numbered participant
from the eligible participant list. If the number of the
odd-numbered participants was not enough at any
clinic, further selection was made by choosing the
even-numbered participants.
However, in the actual selection, we changed the num-
ber of ART clinics from 25 to 34 and the minimum re-
quired number of participants at each clinic from 19 to
14. We randomly selected 15 participants at each clinic.
Thus, the final participants of the study were 510 people.
These changes were intended to increase the probability
and representativeness of the sample.
Data collection training
Before data collection, all interviewers and fieldwork su-
pervisors attended 1-day training on data collection
methods, roles and responsibilities, and ethical consider-
ations. They also partook in a half-day session for tool
pre-testing and reflection. The main objective of the
training was to ensure that all interviewers and supervi-
sors understood the data collection tools and procedures
and followed them consistently. The training was con-
ducted separately in each study site. During the training
sessions, the study protocol was presented to ensure that
all interviewers and supervisors were informed about the
overall goal and objectives of the study. The training also
covered interview techniques, confidentiality, and privacy.
Lastly, interviewers practiced administration of the study
questionnaire and collection of anthropometric and
biochemical measures.
In order to ensure the quality of data, the training also
included quality control elements such as rechecking the
questionnaires, anthropometric and biomedical data, as
well as discussing and resolving issues that might arise
during the fieldwork. Regular review sessions with in-
terviewers were conducted during the survey period to
discuss the progress and communicate any questions,
concerns, and problems that might have occurred dur-
ing the data collection.
Data collection procedures
Data collection was conducted in June 2015. Based on
experience from a Tanzania study looking at prevalence of
diabetes mellitus among people living with HIV [9], bio-
chemical testing was scheduled on the same day as the
survey because many people, especially those who were
not on ART, may not show up the next day. At each ART
clinic, an interviewer administered the questionnaire,
while a trained nurse or midwife working for the selected
ART clinic measured anthropometric and biochemical pa-
rameters. All data collection was conducted in a private
room located at the selected ART clinics.
Eligible participants were informed in advance to fast
after 12 o’clock (midnight) prior to the data collection
day. Participants were appointed to be present at the
clinic early morning starting from 7 am. During the data
collection process, participants were first given an ID
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number and then had their anthropometric and bio-
chemical data collected. Each participant was then given
a light breakfast pack (salted crackers, canned fruit juice,
and bottled drinking water) before starting the interview
in another room. Participants handed their ID number
to the interviewer to be recorded on the questionnaire.
Each participant was given a token after finishing the
interview to mark the end of his/her participation.
Data collection tools
Tanita Glass Digital Bathroom Scale HD-380 (Tanita
Corporation, Tokyo, Japan) was used to measure the
weight (in kilograms) of participants. Their height was
measured in meters using a YELL measuring tape. Body
mass index (BMI) was calculated by dividing the weight
(Kg) by the height (m) squared. Systolic and diastolic
blood pressures in mmHg and heart rate in beats per
minute were taken using an automatic blood pressure
monitor, model BP 3AQ1 (Microlife, Taipei, Taiwan).
Blood pressures and heart rate were measured three
times to ensure the accuracy of the readings. If variations
occurred, the average was taken. Fasting blood glucose
(mg/dL) and total cholesterol (mg/dL) were measured
using EasySure GCU (Bioptik Technology Inc., Taipei,
Taiwan).
A structured questionnaire developed by the WHO,
STEP-Wise Approach to Surveillance [22], was used to
conduct face-to-face interviews. The questionnaire was
translated into Khmer and field tested before being final-
ized for the survey. The questionnaire collected informa-
tion on socio-demographic characteristics (i.e. gender,
type of community, education, marital status, etc.), behav-
ioral risk factors (i.e. smoking, alcohol use, eating habits,
and physical activity), and medical history (i.e. relevant
family medical history and personal history of diabetes
mellitus, hypertension, and hyperlipidemia confirmed
by a healthcare provider).
Working definitions for the key variables were adapted
from the WHO’s guideline [22] and are shown in Table 1.
Data analyses
EpiData version 3 (Odense, Denmark) was used for double
data entry. Descriptive statistics were used to compute
means and standard deviations (SD) for numerical vari-
ables as well as frequencies for ordinal and categorical var-
iables. The cutoffs used for BMI categories were based on
the WHO’s recommendation for Asian populations [23].
The cutoffs used for blood pressures, blood glucose, and
blood cholesterol were taken from the WHO’s STEP-Wise
Approach to Surveillance (WHO, 2009). We used inde-
pendent Student’s t-test for continuous variables and Chi-
square test or Fisher’s exact test for categorical vari-
ables to compare men and women across variables.
Two-sided p-values of less than 0.05 were regarded as
statistically significant. All data were analyzed using
STATA (Lakeway Drive College Station, TX, USA).
Results
Socio-demographic characteristics
This study included 510 people living with HIV re-
cruited from Phnom Penh (n = 132, 25.9%), Takeo
(n = 153, 30.0%), Battambang (n = 119, 23.3%), Pursat
(n = 76, 14.9%), and Siem Reap (n = 30, 5.9%).
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As shown in Table 2, 66.7% of the respondents were
female. The participants’ mean age was 44.8 years old
(SD = 8.4), with 61.6% of them being married or cohab-
iting. The majority (60.2%) of the sample were from
urban communities and 96.7% were on ART. Regarding
education level, 22.6% had no schooling, 72.6% completed
primary and junior high school, and 4.9% completed high
school and university. Their reported occupations in-
cluded farmers (22.0%), laborers (21.4%), self-employed
(19.6%), and office workers (9.2%); while 24.3% were un-
employed. Their mean monthly income in the past year
was USD 87.9 (SD = 70.2).
Table 2 also shows comparisons of the socio-
demographic characteristics among men and women.
Men were significantly older than women (46.4 ± 9.1 vs.
44.0 ± 8.0, p = 0.002). Men were significantly more likely
to be married or cohabiting (81.8% vs. 51.5%, p < 0.001),
while women were significantly more likely to be divorced,
separated, or widowed (14.1% vs. 48.2%, p < 0.001). A
significantly higher proportion of women reported hav-
ing no schooling (8.8% vs. 29.4%, p < 0.001), while a
significantly higher proportion of men reported having
completed primary and junior high school (82.9% vs.
67.4%, p < 0.001). Although a significantly higher pro-
portion of women were unemployed (11.2% vs. 30.9%,
p < 0.001), their mean monthly income was significantly
higher than that of men (USD 60.5 ± 75.0 vs. USD
69.6 ± 74.5, p < 0.001).
Table 2 Comparisons of socio-demographic characteristics among men and women living with HIV
Socio-demographic characteristics Total Men Women P-valuea
Sex 510 (100.0) 170 (33.3) 340 (66.7)
Community Type 0.52
Rural 203 (39.8) 71 (41.8) 132 (38.8)
Urban 307 (60.2) 99 (58.2) 208 (61.2)
Treatment status 0.73
On ART 493 (96.7) 165 (97.1) 328 (96.5)
On pre-ART 17 (3.3) 5 (2.9) 12 (3.5)
Mean age 44.8 ± 8.4 46.4 ± 9.1 44.0 ± 8.0 0.002
Age groups 0.15
Less than 35 43 (8.4) 11 (6.5) 32 (9.4)
35–54 404 (79.2) 132 (77.7) 272 (80.0)
55 and older 63 (12.4) 27 (15.9) 36 (10.6)
Marital status <0.001
Married/cohabiting 314 (61.6) 139 (81.8) 175 (51.5)
Divorced/separated/widowed 188 (36.9) 24 (14.1) 164 (48.2)
Never married 8 (1.6) 7 (4.1) 1 (0.3)
Level of education attained <0.001
No schooling 115 (22.6) 15 (8.8) 100 (29.4)
Completed primary and junior high school 370 (72.6) 141 (82.9) 229 (67.4)
Completed high school and university 25 (4.9) 14 (8.2) 11 (3.2)
Main occupations <0.001
Unemployed 124 (24.3) 19 (11.2) 105 (30.9)
Farmers 112 (22.0) 41 (24.1) 71 (20.9)
Office workers 47 (9.2) 27 (15.9) 20 (5.9)
Laborers 109 (21.4) 50 (29.4) 59 (17.4)
Self-employed 100 (19.6) 28 (16.5) 72 (21.9)
Othersb 18 (3.5) 5 (2.9) 13 (3.8)
Mean monthly income in the past 12 months (USD) 87.9 ± 70.2 60.5 ± 75.0 69.6 ± 74.5 <0.001
Abbreviations: ART antiretroviral therapy, HIV human immunodeficiency virus, USD United States Dollar
Values are numbers (%) for categorical variables and mean ± standard deviation (SD) for continuous variables
aStudent’s t-test was used for continuous variables and Chi-square test or Fisher’s exact test for categorical variables
bOthers included entertainment workers, students, soldiers, police, scavengers, and fishermen
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Tobacco and alcohol use
Tobacco and alcohol use among men and women is re-
ported in Table 3. Of total, 14.7% of the respondents were
current tobacco smokers, 3.7% were current smokeless to-
bacco users, and 11.4% were former tobacco smokers. The
mean age when the participants started smoking was
20.8 years (SD = 7.6) and the mean age when they quit
smoking was 39.1 years (SD = 12.3). On average, a current
smoker reported smoking 10 cigarettes per day (SD = 7.4).
For alcohol use, 54.7% of the respondents reported
having ever consumed a drink containing alcohol such
as beer, wine, or spirits in lifetime. Of these drinkers,
76.3% had consumed it within the last 12 months. Most
people who had consumed alcohol in the last 12 months
reported drinking less than once per month (67.6%),
while 16.7% reported drinking for one to 3 days per
month. Almost 10% reported drinking for 1 to 4 days per
week, while 6.6% reported drinking for more than 5 days
per week. The mean amount of alcohol consumed per day
was 4.8 g (SD = 33.1). The mean number of standard
drink they consumed per day was 0.5 (SD = 3.3).
Table 3 also shows that a significantly higher propor-
tion of men was current smokers (40.6% vs. 1.8%,
p ≤ 0.001) or reported having smoked regularly in the
past (26.5% vs. 3.8%, p < 0.001). However, 5.6% of women
reported using smokeless tobacco such as snuff or chew-
ing, while no men did (p = 0.002). Similar to tobacco, a
significantly higher proportion of men reported drinking
alcohol in lifetime (74.1% vs. 45.0%, p < 0.001) and in the
past 12 months (84.9% vs. 69.3%, p < 0.001). Moreover, a
significantly higher proportion of men reported drinking
alcohol for one to 4 days per week in the past 12 months
(18.7% vs. 0.9%, p < 0.001).
Dietary behaviors
Table 4 shows that, on average, the respondents reported
consuming fruits for 2.5 days per week (SD = 2.1), with
a mean of 1.8 servings (SD = 5.2) on a typical day. They
reported consuming vegetables on an average of 5.6 days
per week (SD = 1.7), with a mean of 2.0 servings
(SD = 0.5) on a typical day. The majority of the respon-
dents (92.4%) reported usually preparing their meals at
home (92.4%). The most commonly used cooking oil
was vegetable oil (95.3%), while 4.3% reported using lard,
and 0.4% reported using animal fat in meal preparation.
A significantly higher proportion of women reported
preparing most of their meals at home (97.9% vs. 81.2%,
p < 0.001).
Physical activities
Table 5 shows that 39.8% of the respondents had a job
that involved mostly sitting or standing with less than
10 min walking per day. However, 21.6% had a job that
involved vigorous activities such as heavy lifting, digging,
or construction work. For those that had jobs involving
vigorous activities, they engaged in them on an average
of 4.6 days (SD = 2.2) per week and 3.2 h per day
(SD = 3.6). On a typical working day, they reported
spending an average of 5.0 h for the work (SD = 3.6).
During leisure times, 11.8% of the respondents reported
spending at least 10 min doing vigorous activities, with a
mean of 4.5 days per week (SD = 2.3) and an average of
Table 3 Comparisons of tobacco and alcohol use among men and women living with HIV
Variables Total Men Women P-valuea
Currently smoke/use tobacco products 75 (14.7) 69 (40.6) 6 (1.8) <0.001
Currently use smokeless tobacco 19 (3.7) 0 (0.0) 19 (5.6) 0.002
Ever smoked regularly, but not a current smoker 58 (11.4) 45 (26.5) 13 (3.8) <0.001
Mean age when first started smoking (years) 20.8 ± 7.6 20.9 ± 7.6 20.0 ± 8.3 0.79
Mean age when stopped smoking (years) 39.1 ± 12.3 39.2 ± 11.6 38.3 ± 17.8 0.87
Mean number of cigarettes smoked per day 10.0 ± 7.4 10.4 ± 7.3 5.8 ± 7.9 0.15
Ever consumed a drink containing alcohol 279 (54.7) 126 (74.1) 153 (45.0) <0.001
Consumed alcohol within the past 12 months 213 (76.3) 107 (84.9) 106 (69.3) <0.001
Frequency of alcohol consumption in the past 12 months
Less than once a month 144 (67.6) 59 (55.1) 85 (80.2)
1–3 days/month 34 (16.0) 21 (19.6) 13 (12.3)
1–4 days/week 21 (9.9) 20 (18.7) 1 (0.9)
5 or more days per week 14 (6.6) 7 (6.5) 7 (6.6) <0.001
Mean standard drink consumed per day 0.5 ± 3.3 0.4 ± 0.7 0.5 ± 4.7 0.75
Mean of ethanol consumed per day (in grams) 4.8 ± 33.1 4.1 ± 6.8 5.5 ± 46.6 0.75
Values are numbers (%) for categorical variables and mean ± standard deviation (SD) for continuous variables
Abbreviations: HIV human immunodeficiency virus
aStudent’s t-test was used for continuous variables and Chi-square test or Fisher’s exact test for categorical variables
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1.0 h per day (SD = 1.0). Nearly half (46.3%) reported en-
gaging in moderate physical activities during their leisure
time, with a mean of 5.1 days per week (SD = 2.2) and an
average of 1.6 h per day (SD = 1.7). The majority (80.6%)
reported walking or using a bicycle for ten continuous mi-
nutes to get to or from a place and sitting or reclining in a
mean duration of 1.6 h (SD = 1.3) on a typical day in the
last 7 days.
Compared to women, a significantly higher proportion
of men reported engaging in vigorous physical activities
both at work (34.1% vs. 15.3%, p < 0.001) and during
leisure times (20.6% vs. 7.4%, p < 0.001).
Anthropometric measures
The anthropometric measures among men and women
in this study are shown in Table 6. The mean height was
1.6 m (SD = 0.1) and the mean weight was 51.8 Kg
(SD = 9.5). The mean BMI score was 21.0 Kg/m2
(SD = 3.3). BMI scores were stratified based on the rec-
ommended cutoffs for Asian populations for under-
weight, normal weight, overweight, and obesity [20]. Out
of the study population, 19.4% were underweight, 17.3%
were overweight, and 4.1% were obese. Of the under-
weight, 67.7% were mildly underweight, 19.2% were mod-
erately underweight, and 13.1% were severely underweight.
History of hypertension, diabetes mellitus, and high
cholesterol
As shown Table 7, 31.4% of the respondents had never
had blood pressure measured; 58.8% had blood pressure
measured within the last 12 months; and 9.8% had blood
pressure measured 1 to 5 years ago. Among those who
reported having blood pressure measured, 8.4% reported
that they were told by a health provider that they had
Table 4 Comparisons of dietary behaviors among men and women living with HIV
Variables Total Men Women P-valuea
Mean time of fruits consumed per week (days) 2.5 ± 2.1 2.3 ± 1.9 2.6 ± 2.2 0.08
Mean number of servings of fruits per day 1.8 ± 5.2 1.3 ± 0.5 2.0 ± 6.3 0.22
Mean number of days of vegetable consumption in a typical week 5.6 ± 1.7 5.7 ± 1.6 5.6 ± 1.8 0.69
Mean number of servings of vegetables per day 2.0 ± 0.5 2.0 ± 0.4 2.0 ± 0.5 0.56
Meals usually prepared at home 471 (92.4) 138 (81.2) 333 (97.9) <0.001
Types of oil/fat most often used for meal preparation in family 0.41
Lard 22 (4.3) 10 (5.9) 12 (3.5)
Animal fat 2 (0.4) 1 (0.6) 1 (0.3)
Vegetable oil 486 (95.3) 159 (93.5) 327 (96.2)
Values are numbers (%) for categorical variables and mean ± standard deviation (SD) for continuous variables
Abbreviations: HIV human immunodeficiency virus
aStudent’s t-test for continuous variables and Chi-square test or Fisher’s exact test for categorical variables
Table 5 Comparisons of physical activities among men and women living with HIV
Variables Total Men Women P-valuea
Job mostly involving sitting/standing with no more than 10 min walking 203 (39.8) 71 (41.8) 132 (38.8) 0.52
Job involving vigorous acts for at least 10 min 110 (21.6) 58 (34.1) 52 (15.3) <0.001
Vigorous activities in a typical week (days) 4.6 ± 2.2 4.7 ± 2.1 4.5 ± 2.3 0.53
Vigorous activities in a typical day (hours) 3.2 ± 3.6 3.8 ± 3.0 2.6 ± 4.1 0.09
Working hours on a typical day (hours) 5.0 ± 3.6 5.7 ± 3.1 4.7 ± 3.7 0.002
Vigorous activities for at least 10 min at a time during leisure (hours) 60 (11.8) 35 (20.6) 25 (7.4) <0.001
Vigorous activities for at least 10 min of leisure time (days) 4.5 ± 2.3 5.4 ± 2.1 3.8 ± 2.2 0.007
Vigorous activities on a typical day of leisure time (hours) 1.0 ± 1.0 0.8 ± 0.6 1.1 ± 1.2 0.22
Moderate activities for at least 10 min at a time during leisure (hours) 236 (46.3) 156 (45.9) 80 (47.1) 0.80
Moderate activities for at least 10 min in a typical week (days) 5.1 ± 2.2) 5.0 ± 2.3 5.2 ± 2.2 0.39
Moderate activities for at least 10 min on a typical day (hours) 1.6 ± 1.7 1.7 ± 2.0 1.5 ± 1.6 0.39
Walked/used bicycle at least 10 min to get to and from a place (hours) 411 (80.6) 134 (78.8) 277 (81.5) 0.48
Sitting/reclining on a typical day in the past 7 days (hours) 1.6 ± 1.3 1.7 ± 1.3 1.6 ± 1.3 0.32
Values are numbers (%) for categorical variables and mean ± standard deviation (SD) for continuous variables
Abbreviations: HIV human immunodeficiency virus
aStudent’s t-test for continuous variables and Chi-square test or Fisher’s exact test for categorical variables
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hypertension. Of those having hypertension, 51.2% re-
ported currently taking medication for hypertension, and
76.7% were on a specially prescribed diet. Most of the
respondents reported having been given some form of
lifestyle counseling: 39.5% were advised to lose weight,
67.4% to stop smoking, and 86.0% to do more exercise.
Of those having an elevated blood pressure, 7.0% re-
ported consulting a traditional healer, and 4.7% reported
currently taking a traditional treatment for elevated
blood pressure. More than a quarter (28.8%) reported a
family history of hypertension.
For diabetes mellitus, 10.0% of the respondents re-
ported having had their blood glucose levels measured
in the last 12 months, 1.0% reported having been diag-
nosed with diabetes mellitus, and 9.2% had a family his-
tory of diabetes mellitus. For blood cholesterol, 7.7%
Table 6 Comparisons of anthropometric measures among men and women living with HIV
Variables Total Men Women P-valuea
Mean BMI score (kg/m2) 21.0 ± 3.3 20.8 ± 2.8 21.2 ± 3.5 0.19
BMI cut-offs 0.36
Underweight (BMI < 18.5 kg/m2) 99 (19.4) 31 (18.2) 68 (20.0)
Normal (BMI 18.5–22.9 kg/m2) 302 (59.2) 108 (63.5) 194 (57.1)
Overweight (BMI 23.0–27.4 kg/m2) 88 (17.3) 27 (15.9) 61 (17.9)
Obese (BMI > 27.5 kg/m2) 21 (4.1) 4 (2.4) 17 (5.0)
Underweight classification 0.86
Mildly (BMI 17.0–18.4 kg/m2) 67 (67.7) 22 (71.0) 45 (66.2)
Moderately (BMI 16.0–16.9 kg/m2) 19 (19.2) 5 (16.1) 14 (20.6)
Severely (BMI <16.0 kg/m2) 13 (13.1) 4 (12.9) 9 (13.2)
Values are numbers (%) for categorical variables and mean ± standard deviation (SD) for continuous variables
Abbreviations: BMI body mass index, HIV human immunodeficiency virus
aStudent’s t-test for continuous variables and Chi-square test or Fisher’s exact test for categorical variables
Table 7 Comparisons of medical history related to diabetes mellitus, hypertension, and hyperlipidemia among men and women
living with HIV
Variables Frequency (%) P-valuea
Total Men Women
Had blood pressure measured by a health provider
Never had blood pressure measured 160 (31.4) 63 (37.1) 97 (28.53)
Within last 12 months 300 (58.8) 89 (52.35) 211 (62.06)
1–5 years ago 50 (9.8) 18 (10.59) 32 (9.41) 0.10
Told by a health provider about having hypertension in last 12 months 43 (8.4) 12 (7.1) 31 (9.1) 0.43
Taking medication for hypertension in last 2 weeksb 22 (51.2) 4 (33.3) 18 (58.1) 0.28
On any special prescribed dietb 33 (76.7) 7 (58.3) 26 (83.9) 0.12
Received advice or treatment to lose weight 17 (39.5) 3 (25.0) 14 (45.2) 0.38
Received advice to stop smoking 29 (67.4) 8 (66.7) 21 (67.7) 0.73
Received advice to start or do more exercise 37 (86.0) 11 (91.7) 26 (83.9) 0.60
Consulted traditional healer for hypertension in last 12 monthsb 3 (7.0) 2 (16.7) 1 (3.2) 0.25
Currently taking any traditional remedy for hypertensionb 2 (4.7) 1 (8.3) 1 (3.2) 0.58
Had a family history of hypertension 147 (28.8) 42 (24.7) 105 (30.9) 0.15
Had blood sugar measured in last 12 months 51 (10.0) 13 (7.7) 38 (11.2) 0.21
Diagnosed with diabetes by health provider 5 (1.0) 2 (1.2) 3 (0.9) 0.75
Had a family history of diabetes 47 (9.2) 17 (10.0) 30 (8.8) 0.67
Had blood cholesterol measured by a health provider in last 12 months 39 (7.7) 11 (6.5) 28 (8.2) 0.48
Told by a health provider about elevated cholesterol in last 12 months 14 (2.8) 3 (1.8) 11 (3.2) 0.34
Abbreviations: HIV human immunodeficiency virus
aChi-square test or Fisher’s exact test was used as appropriate
bOf those having hypertension
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reported having their blood cholesterol level checked in
the last 12 months, and 2.8% reported having been told
by a health provider that their blood cholesterol was
elevated. There was no significant difference in the
prevalence of diabetes mellitus, hypertension, and
hyperlipidemia among men and women.
Prevalence of diabetes mellitus, hypertension, and
hyperlipidemia
Table 8 displays the measures of blood pressure, sugar,
and cholesterol as well as the prevalence of diabetes
mellitus, hypertension, and hyperlipidemia according to
the definitions used in this study. The mean systolic blood
pressure was 116.7 mmHg (SD = 16.1) and the mean dia-
stolic blood pressure was 73.0 mmHg (SD = 10.1). Blood
pressure readings were significantly higher among men
for both systolic (121.3 mmHg ±16.1 vs. 114.4 mmHg
±16.1, p < 0.001) and diastolic (74.9 mmHg ±11.2 vs.
72.0 mmHg ±9.5, p = 0.002) blood pressures. The propor-
tion of people with elevated blood pressure was signifi-
cantly higher among men (14.1% vs. 6.2% p = 0.003).
According to the definition used in this study, 15.1% of
the study sample had hypertension. No significant differ-
ence was found in the prevalence of hypertension among
men and women.
The mean level of fasting blood glucose for the study
population was 106.3 mg/dL (SD = 24.0). Upon meas-
urement, 9.0% of the sample had elevated blood glucose,
and 9.4% had diabetes mellitus based on the definitions
used in this study. Nonetheless, there was no significant
difference between the prevalence of diabetes mellitus
among men and women.
The mean level of fasting blood cholesterol for the sam-
ple was 180.5 mg/dL (SD = 31.0), with 32.9% having
elevated blood cholesterol. The proportion of respondents
with elevated blood cholesterol was significantly higher
among men (41.2% vs. 28.8%, p = 0.005). According to the
definition used in this study, 33.7% had hyperlipidemia.
The proportion of participants with hyperlipidemia was
significantly higher among men (41.2% vs. 30.0%, p = 0.01).
The prevalence of diabetes mellitus and hypercholes-
terolemia was significantly higher in the oldest and
youngest age groups. The prevalence of diabetes mellitus
was 17.5% for 55-year-old and over participants,
followed by 11.6% for less-than-35-year-old participants
and 7.9% for 35–54 year-old participants. The preva-
lence of hypercholesterolemia among those aged of
55 years old and over, less than 35 years old, and of 35–
54 years old was 42.9, 32.2, and 34.9%, respectively. How-
ever, the prevalence of hypertension was increasingly
higher from younger to older age groups. The prevalence
of hypertension among those aged less than 35 years old
was 7.0%, while that of those aged 45–54 years old and
55 years old and older was 12.4 and 38.1%, respectively.
The majority of the participants with NCDs were un-
aware of their condition prior to the study. Only 8.4, 3.3,
and 1% knew they had hypertension, hypercholesterol-
emia, and diabetes mellitus, respectively, before the
study.
Discussion
This is the first study that explored the prevalence rates
of NCDs and related risk factors among people living
with HIV in Cambodia. We found that the prevalence of
diabetes mellitus, hypertension, and hyperlipidemia was
9.4, 15.1, and 33.7%, respectively. There were no statis-
tical differences between the prevalence of hypertension
and diabetes mellitus among men and women.
Table 8 Comparisons of prevalence of hypertension, diabetes mellitus, and hypercholesterolemia among men and women living
with HIV
Variables Total Men Women P-value
Mean systolic blood pressure (mmHg) 116.7 ± 16.1 121.3 ± 15.2 114.4 ± 16.1 <0.001
Mean diastolic blood pressure (mmHg) 73.0 ± 10.1 74.9 ± 11.2 72.0 ± 9.5 0.002
Elevated measured blood pressure 45 (8.8) 24 (14.1) 21 (6.2) 0.003
Having hypertension a 77 (15.1) 31 (18.2) 46 (13.5) 0.16
Mean fasting blood glucose (mg/dL) 106.3 ± 24.0 107.7 ± 24.9 105.6 ± 23.5 0.34
Elevated measured blood glucose 46 (9.0) 16 (9.4) 30 (8.8) 0.83
Having diabetes mellitusb 48 (9.4) 17 (10.0) 31 (9.1) 0.75
Mean total cholesterol (mg/dL) 180.5 ± 31.0 182.6 ± 31.0 179.4 ± 31.0 0.28
Elevated total blood cholesterol 168 (32.9) 70 (41.2) 98 (28.8) 0.005
Having hyperlipidemiac 172 (33.7) 70 (41.2) 102 (30.0) 0.01
Abbreviations: HIV human immunodeficiency virus
aSystolic blood pressure > 140 mmHg and/ or diastolic blood pressure > 90 mmHg and/or diagnosed with high blood pressure and/or diagnosed with
hypertension and/or on treatment for hypertension
bFasting blood glucose level > 110 mg/dL and/or diagnosed with elevated blood glucose and/or diagnosed with diabetes and/or on diabetes treatment
cTotal blood cholesterol level > 200 mg/dL and/or diagnosed with high cholesterol and/or diagnosed with hypercholesterolemia and/or on treatment
for hypercholesterolemia
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However, men had a significantly higher prevalence of
hyperlipidemia. In the general population, the preva-
lence of diabetes mellitus is estimated to be between 3
and 10% and of hypertension to be approximately 11%
[18–20]. We found that 32.9% of people living with
HIV in this study had an elevated level of blood choles-
terol, which was higher than the 20.7% found in the
general population in 2010 [20]. We also found that
9.0% of the sample had elevated blood glucose, which
was higher than that of 2.9% among the general popula-
tion in 2010 [20].
Furthermore, 17.3% of our sample were overweight,
and 4.1% were obese. This prevalence was higher than
that of the general population, which stood at 15.4 and
1.9% for overweight and obesity, respectively, in 2010
[20]. The higher prevalence of NCDs in people living
with HIV has been supported by previous research in
other developing countries such as Nigeria, Tanzania,
Malawi, Botswana, and Zimbabwe [5–10]. Our findings
indicate that this could also be a concern for Cambodia.
This study also measured the prevalence of known risk
factors among people living with HIV. We found consid-
erably high levels of tobacco and alcohol use and low
levels of fruit and vegetable consumption and physical
activity–all factors that put this population at risk of de-
veloping NCDs. The prevalence of tobacco smoking, a
known risk factor for cardiovascular disease [24, 25],
was considerably high, with 14.7% of participants cur-
rently smoking and 11.4% reporting having smoked
regularly in the past. However, this prevalence was lower
than the prevalence of current and daily smoking among
the general population, which was 29.4 and 37.0%, re-
spectively, in 2010 [20]. In our study, 54.7% of the par-
ticipants reported a history of alcohol use; of whom,
75.3% used alcohol within the past 12 months. Alcohol
use has been linked to both cardiovascular disease and
diabetes mellitus [26]. This prevalence is higher than the
2010 prevalence of current alcohol use (50%) among the
general population, of which 45.1% of men and 4.5% of
women engaged in heavy episodic drinking in the past
30 days [20].
People living with HIV in this study consumed a lim-
ited amount of fruits and vegetables. While the WHO
recommends 5 servings of fruits and vegetables per day
[27], our study population consumed fruits on an aver-
age of 2.5 days and vegetables on 5.6 days per week. On
the days they consumed fruits and vegetables, they ate a
mean of 1.8 servings of fruits and 2.0 servings of vegeta-
bles. This is comparable to the fruit and vegetable con-
sumption by the general population. The 2010 survey
found that 84.3% of respondents on average ate less than
5 servings of fruits and/or vegetables per day [20]. Re-
garding physical activity, a high level of physical activity
during leisure time and work has been shown to reduce
the incidence of cardiovascular disease [28]. The WHO
recommends participation in vigorous activities for a
minimum of 3 days per week or moderate activities for a
minimum of 5 days per week [27]. Only about half
(46.3%) of our respondents reported participating in
moderate activities −21.6% had a job involving vigorous
activities, and 11.8% participated in vigorous activities at
home. Because many people participating in vigorous ac-
tivities may also participate in moderate activities, a
large proportion of people living with HIV in this study
may have not been getting an adequate amount of phys-
ical exercise. This level of physical activity is quite lower
than that of the general population. The 2010 survey
depicted that 76.1% of the general population engaged in
high-level physical activities, with the median time of
4 h and 4 min per day [20].
Our study found that women living with HIV have
lower cholesterol, hyperlipidemia, and hypertension than
men living with HIV. Women smoke less and are physic-
ally less active than men. But, women and men do not dif-
fer in their dietary behaviors. These findings suggest that
more efforts should be targeted at reducing the levels of
cholesterol, hyperlipidemia, and hypertension among men
living with HIV. Also, better interventions should be
aimed at encouraging men to quit smoking and women to
exercise more. Finally, both women and men should be
given more education about healthy diets, particularly
fruit and vegetable consumption.
Implications for policies and practices
Findings from this study suggest that there is a need for
initiating tailor-made intervention to prevent, screen,
refer, and treat NCDs in people living with HIV. To
achieve this, policy and programmatic interventions,
promoting integration of NCD and HIV programs are
required. Evidence from other countries have shown that
this can be achieved through development of protocol
for NCD management [29], training of health care pro-
viders on NCDs as many of them may not have up-to-
date knowledge and experience of NCDs [30], providing
treatment for hypertension at HIV clinics [29], and
adapting HIV monitoring and evaluation tools to incorp-
orate NCD patient monitoring indicators [31]. This is
particularly important given that in many countries, HIV
programs are among the few chronic public health care
programs to have country-wide coverage and informa-
tion systems [30, 32].
In addition, educating people living with HIV regard-
ing NCDs will be critical. Evidence from other settings
suggest that most people living with HIV with early
stages of NCDs are generally not aware that they are at
risk [33]. Peer-led community-based screening of diabetes
mellitus and hypertension among people living with HIV
at drop-in centers and their vicinities can be conducted,
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with referrals of those identified with probable symptoms
to health facilities for confirmation of their diagnosis.
Mobile units have been successfully used in South Africa
[34]. Alternatively, combining community-based HIV test-
ing with screening for diabetes mellitus and hypertension
as has been successfully conducted in Uganda [35] can be
implemented. Finally, there is a need to have supportive
policies.
Study limitations
Several limitations in this study should be acknowledged.
First, the representativeness of this sample must be con-
sidered when analyzing, interpreting, and referencing
this study since the majority of the participants were fe-
male (66.7%), lived in urban communities (60.2%), and
most were between the age of 35 to 54 years old (79.2%).
Because we recruited the sample from people receiving
HIV care at ART clinics, we may have missed those who
did not access HIV care and treatment at the selected
ART sites. The study also excluded pregnant women,
and therefore these results cannot be generalized to this
subpopulation. Second, although efforts were made in
an attempt to recruit people living with HIV who were
not currently on ART, nearly all of our participants were
currently on ART. This condition prevented us from ex-
ploring the effects of ART on the development of NCDs.
Thus, the prevalence of NCDs among the study partici-
pants may not reflect that among people living with HIV
not on ART and without access to ART clinics. Third,
the self-reported measures employed in this study may
lead to over and under reporting due to recall and social
desirability biases. Fourth, the use of a portable
capillary-based method of testing for blood glucose and
cholesterol levels may have lower levels of reliability and
validity than laboratory-based methods. Lastly, this
cross-sectional study may not capture the slowly devel-
oping nature of NCDs.
Conclusions
We found considerably high levels of diabetes mellitus,
hypertension, hyperlipidemia, and known risk factors in
adult people living with HIV in this study that put them
at risk for future NCD-related morbidity and mortality.
A high proportion of the participants did not receive
regular health checkups on these diseases. Albeit receiving
some lifestyle and dietary advice from health providers,
tobacco and alcohol use remained high (particularly for
men), while levels of physical activity (particularly for
women) and consumption of fruits and vegetables
remained low. The levels of most NCDs and health be-
haviors among this HIV-positive population were
higher and worse than those among the general popula-
tion. Distinctions in the levels of diseases and in health
behaviors were found among the study participants.
Women living with HIV have lower cholesterol, hyperlip-
idemia, and hypertension than men living with HIV.
Women smoke less and are physically less active than
men. These variations suggest that interventions need to
be tailor-made and gender-specific, targeting men and
women with their specific diseases and behaviors.
The overall findings of this study are alarming since
they add to the concern for the overlapping epidemic of
HIV and NCDs, and these multiple risk factors may
complicate the HIV conditions in this vulnerable popula-
tion. Policy and programmatic interventions, promoting
integration of NCD and HIV programs people living
with HIV are required. More studies are needed to further
understand the risks in this population and to understand
how to better deliver services addressing NCDs to this
vulnerable population.
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